Could a common antibiotic wake up the sleepy brain?

NCT ID NCT04026958

First seen Aug 07, 2026 ยท Last updated Aug 07, 2026

Summary

This study tests whether clarithromycin, an antibiotic, can reduce excessive daytime sleepiness in people with narcolepsy or idiopathic hypersomnia. Participants receive either clarithromycin or a placebo for 14 days. Researchers will measure changes in sleepiness, brain activity, inflammation, and gut bacteria to understand how the drug might work. The goal is to see if this antibiotic could be a new way to help people stay awake during the day.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Clarithromycin (an antibiotic) taken as 500 mg twice daily for 14 days, compared to placebo.
What this could lead to
If effective, clarithromycin could offer a new treatment option for people with narcolepsy or idiopathic hypersomnia to reduce daytime sleepiness, potentially improving daily functioning.
What could go wrong
This is a phase 2 trial with a relatively small number of participants, so results may not be definitive. The antibiotic may cause side effects like gastrointestinal issues, and its effectiveness for sleepiness is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC HYPERSOMNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Emory Sleep Center

    Atlanta, Georgia, 30329, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.